These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29950838)

  • 1. Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations.
    Mayerova M; Ustohal L; Jarkovsky J; Pivnicka J; Kasparek T; Ceskova E
    Neuropsychiatr Dis Treat; 2018; 14():1535-1543. PubMed ID: 29950838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].
    Papetti F; Morel-Pingault V; Buisse V; Maziere L; Banayan M; Thauby S; Besnard T; Darcourt G; Pringuey D
    Encephale; 2007 Oct; 33(5):811-8. PubMed ID: 18357853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrations in plasma clozapine levels in schizophrenic and schizoaffective patients.
    Iglesias García C; Iglesias Alonso A; Bobes J
    Rev Psiquiatr Salud Ment; 2017; 10(4):192-196. PubMed ID: 28844295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged <18 years: data from a therapeutic drug monitoring service, 1994-2010.
    Couchman L; Bowskill SV; Handley S; Patel MX; Flanagan RJ
    Early Interv Psychiatry; 2013 May; 7(2):122-30. PubMed ID: 22747759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying intraindividual variations in plasma clozapine levels: a population pharmacokinetic approach.
    Lee J; Bies R; Takeuchi H; Fervaha G; Bhaloo A; Powell V; Remington G
    J Clin Psychiatry; 2016 May; 77(5):681-7. PubMed ID: 27136679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients.
    Rostami-Hodjegan A; Amin AM; Spencer EP; Lennard MS; Tucker GT; Flanagan RJ
    J Clin Psychopharmacol; 2004 Feb; 24(1):70-8. PubMed ID: 14709950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics.
    Lane HY; Chang YC; Chang WH; Lin SK; Tseng YT; Jann MW
    J Clin Psychiatry; 1999 Jan; 60(1):36-40. PubMed ID: 10074876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of smoking cessation on plasma clozapine concentrations in male patients with schizophrenia during the COVID-19 pandemic.
    Ma B; Fan H; Qi S; Yang F; An H
    Front Psychiatry; 2023; 14():1256264. PubMed ID: 37779619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring of clozapine and relapse--a retrospective study of routine clinical data.
    Ulrich S; Baumann B; Wolf R; Lehmann D; Peters B; Bogerts B; Meyer FP
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):3-13. PubMed ID: 12564740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine exposure and the impact of smoking and gender: a population pharmacokinetic study.
    Ng W; Uchida H; Ismail Z; Mamo DC; Rajji TK; Remington G; Sproule B; Pollock BG; Mulsant BH; Bies RR
    Ther Drug Monit; 2009 Jun; 31(3):360-6. PubMed ID: 19349931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure.
    Wills KH; Behan SJ; Nance MJ; Dawson JL; Polasek TM; Hopkins AM; van Dyk M; Rowland A
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056943
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response.
    Mauri MC; Volonteri LS; Colasanti A; Fiorentini A; De Gaspari IF; Bareggi SR
    Clin Pharmacokinet; 2007; 46(5):359-88. PubMed ID: 17465637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining concentration-dependent toxicity of clozapine: role of therapeutic drug monitoring.
    Khan AY; Preskorn SH
    J Psychiatr Pract; 2005 Sep; 11(5):289-301. PubMed ID: 16184070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram.
    Perry PJ; Bever KA; Arndt S; Combs MD
    Biol Psychiatry; 1998 Oct; 44(8):733-8. PubMed ID: 9798077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring of clozapine treatment. Therapeutic threshold value for serum clozapine concentrations.
    Olesen OV
    Clin Pharmacokinet; 1998 Jun; 34(6):497-502. PubMed ID: 9646010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction.
    Wiss FM; Allemann SS; Meyer Zu Schwabedissen HE; Stäuble CK; Mikoteit T; Lampert ML
    Front Psychiatry; 2024; 15():1397876. PubMed ID: 38742124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993-2007.
    Couchman L; Morgan PE; Spencer EP; Flanagan RJ
    Ther Drug Monit; 2010 Aug; 32(4):438-47. PubMed ID: 20463634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma amisulpride levels in schizophrenia or schizoaffective disorder.
    Bergemann N; Kopitz J; Kress KR; Frick A
    Eur Neuropsychopharmacol; 2004 May; 14(3):245-50. PubMed ID: 15056484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables.
    Diaz FJ; Santoro V; Spina E; Cogollo M; Rivera TE; Botts S; de Leon J
    Pharmacopsychiatry; 2008 May; 41(3):81-91. PubMed ID: 18484549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of clozapine and norclozapine in Mexican schizophrenia patients.
    González-Esquivel DF; Castro N; Ramírez-Bermúdez J; Custodio V; Rojas-Tomé S; Castro-Román R; Jung-Cook H
    Arzneimittelforschung; 2011; 61(6):335-9. PubMed ID: 21827043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.